L. Long

Evaluation of the Antifungal Activity of the Novel Oral Glucan Synthase Inhibitor SCY-078, Singly and in Combination, for the Treatment of Invasive Aspergillosis

Mahmoud A. Ghannoum, L. Long, Emily L. Larkin et al. · Antimicrobial Agents and Chemotherapy · 2018 · 80 citations · Full text

Industrial Mycology, Invasive Aspergillosis, Antimicrobial Drug Discovery +15

VT-1161 Dosed Once Daily or Once Weekly Exhibits Potent Efficacy in Treatment of Dermatophytosis in a Guinea Pig Model

Edward P. Garvey, W. HOEKSTRA, William R. Moore et al. · Antimicrobial Agents and Chemotherapy · 2015 · 57 citations · Full text

Evaluation of Antifungal Efficacy in an Optimized Animal Model of<i>Trichophyton</i><i>mentagrophytes</i>-Dermatophytosis

Mahmoud A. Ghannoum, Mozammal Hossain, L. Long et al. · Journal of Chemotherapy · 2004 · 50 citations

A Novel 1,3-Beta- <scp>d</scp> -Glucan Inhibitor, Ibrexafungerp (Formerly SCY-078), Shows Potent Activity in the Lower pH Environment of Vulvovaginitis

Emily L. Larkin, L. Long, N. Isham et al. · Antimicrobial Agents and Chemotherapy · 2019 · 48 citations · Full text

Efficacy of Ibrexafungerp (SCY-078) against Candida auris in an <i>In Vivo</i> Guinea Pig Cutaneous Infection Model

Mahmoud A. Ghannoum, N. Isham, D. Angulo et al. · Antimicrobial Agents and Chemotherapy · 2020 · 36 citations · Full text